Transcriptional alterations in the left ventricle of three hypertensive rat models

Physiological Genomics

Volumn 27, Issue 3, 2006, Pages 295-308

  Cerutti, Catherine ^a   Kurdi, Mazen ^a   Bricca, Giampiero ^a   Hodroj, Wassim ^a   Paultre, Christian ^a   Randon, Jacques ^a   Gustin, Marie Paule ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Angiotensin; Cardiac hypertrophy; Hypertension; Microarray

Indexed keywords

RNA; SIALYLTRANSFERASE; CMP N ACETYLNEURAMINATE ALPHA N ACETYLGALACTOSAMINIDE ALPHA 2,6 SIALYLTRANSFERASE; CMP-N-ACETYLNEURAMINATE-ALPHA-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE; REN2 PROTEIN, MOUSE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR PARAMETERS; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEREDITY; HETEROZYGOSITY; HYPERTENSION; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; TRANSGENIC RAT; UNINDEXED SEQUENCE; X CHROMOSOME INACTIVATION; ANIMAL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HEART VENTRICLE; METABOLISM; MOUSE; PATHOLOGY; SPECIES DIFFERENCE; TRANSGENIC ANIMAL; WISTAR KYOTO RAT;

RATTUS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; GENE EXPRESSION PROFILING; HEART VENTRICLES; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RENIN; SIALYLTRANSFERASES; SPECIES SPECIFICITY; TRANSCRIPTION, GENETIC;

EID: 34248194221     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00318.2005     Document Type: Article

References (30)

1. Arnett DK, de las Fuentes L, and Broeckel U. Genes for left ventricular hypertrophy. Curr Hypertens Rep 6: 36-41, 2005.
2. Aronow BJ, Toyokawa T, Canning A, Haghighi K, Delling U, Kranias E, Molkentin JD, and Dorn JW 2nd. Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy. Physiol Genomics 6: 19-28, 2001.
3. Bell D, Kelso EJ, Argent CCH, Lee GR, Allen AR, and McDermott BJ. Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat. Cardiovasc Pathol 13: 71-78, 2004.
4. Booz GW. Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system. Hypertension 45: 341-346, 2005.
5. Bubikat A, De Windt LJ, Zetsche B, Fabritz L, Sickler H, Eckardt D, Godecke A, Baba HA, and Kuhn M. Local atrial natriuretic peptide signaling prevents hypertensive cardiac hypertrophy in endothelial nitric-oxide synthase-deficient mice. J Biol Chem 280: 21594-21599, 2005.
6. Chassagne C, Wisnewsky C, and Schwartz K. Antithetical accumulation of myosin heavy chain but not alpha-actin mRNA isoforms during early stages of pressure-overload-induced rat cardiac hypertrophy. Circ Res 72: 857-864, 1993.
7. Crook JR, Goldman JH, Dalziel M, Madden B, and McKenna WJ. Increased ventricular sialylation in patients with heart failure secondary to ischemic heart disease. Clin Cardiol 20: 455-458, 1997.
8. Deschepper CF, Masciotra S, Zahabi A, Boutin-Ganache I, Picard S, and Reudelhuber TL. Functional alterations of the Nppa promoter are linked to cardiac ventricular hypertrophy in WKY/WKHA rat crosses. Circ Res 88: 223-228, 2001.
9. Friddle CJ, Koga T, Rubin EM, and Bristow J. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci USA 97: 6745-6750, 2000.
10. Heymans S, Schroen B, Vermeersch P, Milting H, Gao F, Kassner A, Gillijns H, Herijgers P, Flameng W, Carmeliet P, Van de Werf F, Pinto YM, and Janssens S. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 112: 1136-1144, 2005.
11. Hubner N, Wallace CA, Zimdahl H, Petretto E, Schulz H, Maciver F, Mueller M, Hummel O, Monti J, Zidek V, Musilova A, Kren V, Causton H, Game L, Born G, Schmidt S, Muller A, Cook SA, Kurtz TW, Whittaker J, Pravenec M, and Aitman TJ. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet 37: 243-253, 2005.
12. Kato N, Hyne G, Bihoreau MT, Gauguier D, Lathrop GM, and Rapp JP. Complete genome searches for quantitative trait loci controlling blood pressure and related traits in four segregating populations derived from Dahl hypertensive rats. Mamm Genome 10: 259-265, 1999.
13. Knuiman MW, Watts GF, and Divitini ML. Is sialic acid an independent risk factor for cardiovascular disease? A 17-year follow-up study in Busselton, Western Australia. Ann Epidemiol 14: 627-632, 2004.
14. Kurdi M, Cerutti C, Randon J, McGregor L, and Bricca G. Macroarray analysis in the hypertrophic left ventricle of renin-dependent hypertensive rats: identification of target genes for renin. J Renin Angiotensin Aldosterone Syst 5: 72-78, 2004.
15. Kurdi M, Randon J, Cerutti C, and Bricca G. Increased expression of IL-6 and LIF in the hypertrophied left ventricle of TGR(mRen2)27 and SHR rats. Mol Cell Biochem 269: 95-101, 2005.
16. Larkin JE, Frank BC, Gaspard RM, Duka I, Gavras H, and Quackenbush J. Cardiac transcriptional response to acute and chronic angiotensin II treatments. Physiol Genomics 18: 152-166, 2004.
17. Mullins JJ, Peters J, and Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344: 541-544, 1990.
18. Ohta K, Kim S, and Iwao H. Role of angiotensin-converting enzyme, adrenergic receptors, and blood pressure in cardiac gene expression of spontaneously hypertensive rats during development. Hypertension 28: 627-634, 1996.
19. Pravenec M, Zidek V, Musilova A, Vorlicek J, Kren V, St Lezin E, and Kurtz TW. Genetic isolation of a blood pressure quantitative trait locus on chromosome 2 in the spontaneously hypertensive rat. J Hypertens 19: 1061-1064, 2001.
20. Rysa J, Leskinen H, Ilves M, and Ruskoaho H. Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure. Hypertension 45: 927-933, 2005.
21. Schroen B, Heymans S, Sharma U, Blankesteijn WM, Pokharel S, Cleutjens JP, Porter JG, Evelo CT, Duisters R, van Leeuwen RE, Janssen BJ, Debets JJ, Smits JF, Daemen MJ, Crijns HJ, Bornstein P, and Pinto YM. Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ Res 95: 515-522, 2004.
22. Strom CC, Kruhoffer M, Knudsen S, Stensgaard-Hansen F, Jonassen TEN, Orntoft TF, Haunso S, and Sheikh SP. Identification of a core set of genes that signifies pathways underlying cardiac hypertrophy. Compar Funct Genomics 5: 459-470, 2004.
23. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 79: 215-262, 1999.
24. Twigger SN, Pasko D, Nie J, Shimoyama M, Bromberg S, Campbell D, Chen J, Cruz Nd Fan C, Foote C, Harris G, Hickmann B, Ji Y, Jin W, Li D, Mathis J, Nenasheva N, Nigam R, Petri V, Reilly D, Ruotti V, Schauberger E, Seiler K, Slyper R, Smith J, Wang W, Wu W, Zhao L, Zuniga-Meyer A, Tonellato PJ, Kwitek AE, and Jacob HJ. Tools and strategies for physiological genomics: the Rat Genome Database. Physiol Genomics 23: 246-256, 2005.
25. van Bilsen M and Chien K. Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducible gene expression. Cardiovasc Res 27: 1140-1149, 1993.
26. Vecchione C, Fratta L, Rizzoni D, Notte A, Poulet R, Porteri E, Frati G, Guelfi D, Trimarco V, Mulvany MJ, Agabiti-Rosei E, Trimarco B, Cotecchia S, and Lembo G. Cardiovascular influences of α1b-adrenergic receptor defect in mice. Circulation 105: 1700-1707, 2002.
27. Vincent M and Sassard J. Lyon strains. In: Handbook of Hypertension. Genetic Models of Hypertension, edited by Swales JD. Oxford: Blackwell Scientific, 1994, p. 455-457.
28. Weinberg EO, Mirotsou M, Gannon J, Dzau VJ, Lee RT, and Pratt RE. Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics 12: 113-127, 2003.
29. Wellner M, Dechend R, Park JK, Shagdarsuren E, Al Saadi N, Kirsch T, Gratze P, Schneider W, Meiners S, Fiebeler A, Haller H, Luft FC, and Muller DN. Cardiac gene expression profile in rats with terminal heart failure and cachexia. Physiol Genomics 20: 256-267, 2005.
30. Zhao M, Chow A, Powers J, Fajardo G, and Bernstein D. Microarray analysis of gene expression after transverse aortic constriction in mice. Physiol Genomics 19: 93-105, 2004.